Erina Nakanishi

The University of Osaka

Papers

1

Total Citations

7

H-Index

1

About

Erina Nakanishi is a radiation oncologist whose research focuses on advancing stereotactic ablative body radiotherapy (SABR), particularly for metastatic lung tumors. Her most-cited work investigates the use of the CyberKnife system—a robotic, image-guided platform that delivers ultra-precise, high-dose radiation from hundreds of angles. By demonstrating that a central dose escalation within the gross tumor volume is feasible and safe, she has contributed to improving local control while minimizing damage to surrounding healthy tissue. This approach is especially valuable for treating challenging central or perihilar metastases, where conventional radiotherapy risks toxicity. With her 2023 study already garnering 7 citations, Nakanishi’s work is gaining traction among clinicians seeking to optimize SABR protocols. Her contributions highlight the potential of real-time motion tracking and steep dose gradients to expand the therapeutic window for oligometastatic disease. For students and researchers, Nakanishi exemplifies how technical innovation in radiation delivery can directly translate into more effective, patient-tailored cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Stereotactic ablative body radiotherapy with a central high dose using CyberKnife for metastatic lung tumors
7 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: The University of Osaka

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago